Ozempic (semaglutide) Shortage

Written by Dr. Kate McCann
23rd December 2022

HPRA and Novo Nordisk have advised doctors that there is a shortage of the diabetic drug Ozempic (semaglutide) through February 2023.

Patients using Ozempic® should be made aware of this supply shortage and that patients at risk of running out of Ozempic® are safely switched to another glucagon-like
peptide-1 (GLP-1) receptor agonist or other suitable alternatives based on your doctor’s clinical judgement.

Delayed awareness of the out-of-stock situation may result in patients missing the required doses, which may have clinical consequences such as hyperglycaemia.

For important information about the shortage of Ozempic, you can read more here:

 http://www.hpra.ie/docs/default-source/Shortages-Docs/ozempic-shortage_jan-2023_dear-hcp_21dec2022.pdf

 

Comments

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Healthy Back to School: Immune-boosting and “Crechitis”

 All this week is #HealthyBackToSchool series.   It is only a matter of days before the online parent groups are full of despair at suddenly finding their young child out of school – just days after starting – with illnesses.  “Is there something going around?”  This...

Hot Lunch Controversy? Oh, let’s weight in!

My children are, again, going to get the school hot lunch programme this year. Really? Yes. Here's why: 1. Facts Not Fears: Much of the fear-mongering around the content of the lunch programme are by the same supermarket influencers and their tired, attention-seeking...

Healthy Back Loo School

An bhfuil cead agam dul go dtí an leithreas? If your child - or teen - is back to school, you've probably asked them how they like their new teacher or what day PE is.  But -- have you asked them about the toilets? Yes, it's a thing.  Look, if it's not a thing for...

Related Posts

Lifestyle Medicine Consultations

Get Started Today